Tag: Astrazeneca press release
New Analyses of Two AZD7442 COVID-19 Phase III Trials In High-Risk Populations Confirm Robust...
New data from the AZD7442 COVID-19 PROVENT prevention and TACKLE outpatient treatment Phase III trials showed robust efficacy from a one-time intramuscular (IM) dose...
